Centessa Pharmaceuticals plc ADR [CNTA] stock prices are down -7.87% to $15.91 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CNTA shares have lost -5.24% over the last week, with a monthly amount drifted -1.06%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] stock has seen the most recent analyst activity on September 03, 2025, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $31. On July 21, 2025, Truist initiated with a Buy rating and assigned a price target of $30 on the stock. Needham started tracking the stock assigning a Buy rating and suggested a price target of $35 on May 28, 2025. Chardan Capital Markets initiated its recommendation with a Buy and recommended $30 as its price target on May 08, 2025. Piper Sandler started tracking with a Overweight rating for this stock on March 31, 2025, and assigned it a price target of $38. In a note dated January 07, 2025, TD Cowen initiated an Buy.
The stock price of Centessa Pharmaceuticals plc ADR [CNTA] has been fluctuating between $9.60 and $19.09 over the past year. Currently, Wall Street analysts expect the stock to reach $23.5 within the next 12 months. Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] shares were valued at $15.91 at the most recent close of the market. An investor can expect a potential return of 47.71% based on the average CNTA price forecast.
Analyzing the CNTA fundamentals
Gross Profit Margin for this corporation currently stands at 0.94% with Operating Profit Margin at -12.94%, Pretax Profit Margin comes in at -14.2%, and Net Profit Margin reading is -14.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -0.56 and Total Capital is -0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.72 points at the first support level, and at 13.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.39, and for the 2nd resistance point, it is at 18.87.
Ratios To Look Out For
It’s worth pointing out that Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA]’s Current Ratio is 10.12. As well, the Quick Ratio is 10.12, while the Cash Ratio is 1.49. Considering the valuation of this stock, the price to sales ratio is 141.47, the price to book ratio is 6.18.
Transactions by insiders
Recent insider trading involved HUSSAIN IQBAL J, General Counsel, that happened on Aug 15 ’25 when 6000.0 shares were sold. Officer, HUSSAIN IQBAL J completed a deal on Aug 15 ’25 to buy 6000.0 shares. Meanwhile, President, Orexin Program Accardi Mario Alberto sold 8322.0 shares on Jul 29 ’25.
